Results 71 to 80 of about 312,725 (94)

Lux

Ejemplar en el que figuran impresos los estatutos por los que se regía la entidad "LUX", Compañía Anónima Española de Seguros y Reaseguros. Figuran estructurados en 5 Títulos y 39 Artículos, con los siguientes apartados: Denominación, objeto, duración y ...
Lux
core  

First Performance of Transjugular Transcatheter Tricuspid Valve Replacement with the Lux-Valve Plus System in Latin America. A Case Report

Arquivos Brasileiros de Cardiologia
Vinicius Esteves, Pedro Beraldo de Andrade, Sergio Kreimer, Fernanda Almeida Esteves, Francisco Monteiro de Almeida Magalhães, Thomas Modine   +5 more
openaire   +3 more sources

82264 | Recurrent Tricuspid Regurgitation After LuX-Valve Transcatheter Tricuspid Valve Replacement: Impact of Cardiac Implantable Electronic Devices

Structural Heart
Sami Alnasser, Kitae Kim, Kendra Derry, Gianluigi Bisleri, Geraldine Ong, Neil Fam   +5 more
openaire   +1 more source

72150 | 30-Day TRINITY Trial Outcomes in Large-Anatomies Patients Using LuX-Valve Plus Transjugular Tricuspid Valve Replacement System

Structural Heart
Thomas Modine, Fanglin Lu, Tobias Ruf, Thilo Noack, Tobias Kister, Jörg Hausleiter, Thomas Stocker, Lionel Leroux, Didier Tchetche, Nicolas Dumonteil, Helene Eltchaninoff, Eric Durand, Mohammod Nejjari, Julien Dreyfus, Bernard Prendergast, Simon Redwood, Tiffany Patterson, Rodrigo Estevez Loureiro, Miguel Piñón, Ole De Backer, Jacon Moller, Mao Chen, Fei Chen, Guangyuan Song, Zhengming Jiang, Guillaume Leurent, Erwan Donal, Ignacio Cruz Gonzalez, Candela Perez, Omar Abdul-Jawad Altisent, Xavier Freixa, Augustin Coisne, Arnaud Sudre, Jean-Francois Obadia, Gilles Rioufol, Thomas Cuisset, Pierre Deharo, Folliguet Thierry, Emmanuel Teiger, Patricia Mahia, Luis Nombela-Franco, Anson Cheung, Patrizio Lancellotti, Christelle Diakov, Charis Costopoulos, Junbo Ge, Stephan von Bardeleben   +46 more
openaire   +1 more source

83523 | Trinity Trial 12-Month Outcomes in Large Annulus Patients (LAP) Using LuX-Valve Plus Transjugular Tricuspid Valve Replacement System

Structural Heart
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Twelve-Month Outcomes of the LuX-Valve for Transcatheter Treatment of Severe Tricuspid Regurgitation.

EuroIntervention, 2021
Severe functional tricuspid regurgitation is associated with adverse clinical outcomes. Conventional surgical risk for patients with advanced tricuspid regurgitation stage is high. Alternative approaches are therefore required.The purpose of this study was to investigate the feasibility, technical details, and midterm outcomes of implantation of a ...
Zhenxing Sun
exaly   +3 more sources

Transcatheter Tricuspid Valve Replacement With LuX-Valve Device: Overview of Key Echocardiographic Considerations

Catheterization and Cardiovascular Interventions
AbstractTricuspid regurgitation is a common valve disease with high incidence and poor prognosis. For elderly patients and those with a history of open heart surgery, second thoracotomy and valve replacement carry a high risk. Transcatheter tricuspid valve replacement (TTVR) has become an alternative treatment for patients with high surgical risk.
Xin Wei, Mao Chen
exaly   +3 more sources

A First-in-Human Study of Transjugular Transcatheter Tricuspid Valve Replacement With the LuX-Valve Plus System.

EuroIntervention, 2023
Yuan, Zhang, Fanglin, Lu, Wei, Li, Shasha, Chen, Mingfei, Li, Xiaochun, Zhang, Cuizhen, Pan, Fan, Qiao, Daxin, Zhou, Wenzhi, Pan, Junbo, Ge   +10 more
exaly   +3 more sources

Treatment of Severe Tricuspid Regurgitation Induced by Permanent Pacemaker Lead: Transcatheter Tricuspid Valve Replacement With the Guidance of 3-Dimensional Printing

Frontiers in Cardiovascular Medicine, 2023
BackgroundLead-induced tricuspid regurgitation is one of the complications after permanent pacemaker implantation (PPI) and refers to tricuspid regurgitation (TR) caused by the lead in the right ventricle (RV).ObjectivesTo study the clinical ...
Xin Meng, Fanglin Lu, Yanyan Ma
exaly   +3 more sources

Transjugular Transcatheter Tricuspid Valve Implantation of LuX-Valve Bioprosthesis in a Preclinical Model

Journal of Cardiovascular Translational Research, 2022
The purpose of this preclinical study in a sheep model was to confirm the feasibility and safety of the LuX-Valve transjugular tricuspid valve (TV) replacement apparatus and to optimize the implantation procedure before beginning first-in-man study. The LuX-Valve was implanted in a sheep model (n = 8) via transjugular approach.
Xiao-Ping Ning, Jing-Yi Cao, Meng-Xing Li, He Wang, Ning Li, Zhi-Gang Song, Zhi-Yun Xu, Lin Han, Guang-Wei Zhou, Xiao-Hong Liu, De-Jun Gong, Fan Qiao, Fang-Lin Lu   +12 more
openaire   +2 more sources